Skip to main content

Advertisement

Log in

Infliximab-Related Hepatitis: A Case Study and Literature Review

  • Case Report
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Abbreviations

TNF:

Tumor necrosis factor

DILI:

Drug induced liver injury

AIH:

Autoimmune hepatitis

References

  1. Subramaniam K, Chitturi S, Brown M. Infliximab-induced autoimmune hepatitis in Crohn’s disease treated with budesonide and mycophenolate. Inflamm Bowel Dis. 2011;17:E149–E150.

    Article  PubMed  CAS  Google Scholar 

  2. Doyle A, Forbes G, Kontorinis N. Autoimmune hepatitis during infliximab therapy for Crohn’s disease: a case report. J Crohns Colitis. 2011;5:253–255.

    Article  PubMed  Google Scholar 

  3. Goujon C, Dahel K, Bérard F, Guillot I, Gunera-Saad N. Autoimmune hepatitis in two psoriasis patients treated with infliximab. J Am Acad Dermatol. 2010;63:43–44.

    Article  Google Scholar 

  4. Carlsen KM, Riis L, Madsen OR. Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercep. Clin Rheumatol. 2009;28:1001–1003.

    Article  PubMed  CAS  Google Scholar 

  5. Polin Y, Thérien G. Drug-induced hepatitis and lupus during infliximab treatment for psoriasis: case report and literature review. J Cutan Med Surg. 2010;14:100–104.

    Google Scholar 

  6. Cravo M, Silva R, Serrano M. Autoimmune hepatitis induced by infliximab in a patient with Crohn’s disease with no relapse after switching to adalimumab. Biodrugs. 2010;24:25–27.

    Article  PubMed  Google Scholar 

  7. Thiéfin G, Morelet A, Heurgué A, Diebold MD, Eschard JP. Infliximab-induced hepatitis. Absence of cross-toxicity with etanercept. Joint Bone Spine. 2008;75:737–739.

    Article  PubMed  Google Scholar 

  8. Marques M, Magro F, Cardoso H, Carneiro F. Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis. Inflamm Bowel Dis. 2008;14:723–725.

    Article  PubMed  CAS  Google Scholar 

  9. Ozorio G, McGarity B, Bak H, Jordan AS, Lau H, Marshall C. Autoimmune hepatitis following infliximab therapy for ankylosing spondylitis. Med J Aust. 2007;187:524–526.

    PubMed  Google Scholar 

  10. Tobon GJ, Cañas C, Jaller JJ, Restrepo JC, Anaya JM. Serious liver disease induced by infliximab. Clin Rheumatol. 2007;26:578–581.

    Article  PubMed  Google Scholar 

  11. Germano V, Picchianti A, Baccano G, et al. Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis. Ann Rheum Dis. 2005;64:1519–1520.

    Article  PubMed  CAS  Google Scholar 

  12. Ojiro K, Naganuma M, Ebinuma H, et al. Reactivation of hepatitis B in a patient with Crohn’s disease treated using infliximab. J Gastroenterol. 2008;43:397–401.

    Article  PubMed  Google Scholar 

  13. Madonia S, Orlando A, Scimeca D, Olivo M, Rossi F, Cottone M. Occult hepatitis B and infliximab-induced HBV reactivation. Inflamm Bowel Dis. 2007;13:508–509.

    Article  PubMed  Google Scholar 

  14. Millonig G, Kern M, Ludwiczek O, Nachbaur K, Vogel W. Subfulminant hepatitis B after infliximab in Crohn’s disease: need for HBV-screening? World J Gastroenterol. 2006;12:974–976.

    PubMed  Google Scholar 

  15. Ueno Y, Tanaka S, Shimamoto M, et al. Infliximab therapy for Crohn’s disease in a patient with chronic hepatitis B. Dig Dis Sci. 2005;50:163–165.

    Article  PubMed  Google Scholar 

  16. Michel M, Duvoux C, Hezode C, Cherqui D. Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for and adult onset Still’s disease. J Rheumatol. 2003;30:1624–1625.

    PubMed  Google Scholar 

  17. Kuwabara H, Fukuda A, Tsuda Y, Shibayama Y. Precore mutant hepatitis B virus associated fulminant hepatitis during infliximab therapy for rheumatoid arthritis. Clin Rheumatol. 2010;29:449–450.

    Article  Google Scholar 

  18. Wahie S, Alexandroff A, Reynolds NJ. Hepatitis: a rare, but important, complication of infliximab therapy for psoriasis. Clin Exp Dermatol. 2006;31:460–461.

    Article  PubMed  CAS  Google Scholar 

  19. Ierardi E, Della Valle N, Nacchiero MC, De Francesco V, Stoppino G, Panella C. Onset of liver damage after a single administration of infliximab in a patient with refractory ulcerative colitis. Clin Drug Invest. 2006;26:673–676.

    Article  Google Scholar 

  20. García Aparicio AM, Rey JR, Sanz AH, Alvarez JS. Successful treatment with etanercep in a patient with hepatotoxicity closely related to infliximab. Clin Rheumatol. 2007;26:811–813.

    Article  PubMed  Google Scholar 

  21. Fairhurst A, Sheehan-Dare R. Autoimmune hepatitis associated with infliximab in a patient with palmoplantar pustular psoriasis. Clin Exp Dermatol. 2008;34:402–425.

    Google Scholar 

  22. Kluger N, Girard C, Guillot B, Bessis D. Efficiency and safety of etanercep after acute hepatitis induced by infliximab for psoriasis. Acta Derm-Venereol. 2009;89:332–333.

    Article  PubMed  Google Scholar 

  23. Soto Fernández S, Gónzalez Carro P, de Pedro Esteban A, et al. Infliximab-induced hepatitis in a patient with Crohn’s disease. Gastroenterol Hepatol. 2006;29:321–322.

    Article  PubMed  Google Scholar 

  24. Mancini S, Amarotti E, Vecchio S, Ponz de Leon M, Roncucci L. Infliximab-related hepatitis: discussion of a case and review of the literature. Intern Emerg Med. 2010;5:193–200.

    Article  PubMed  Google Scholar 

  25. Menghini VV, Arora AS. Infliximab-associated reversible cholestatic liver disease. Mayo Clin Proc. 2001;76:84–86.

    Article  PubMed  CAS  Google Scholar 

  26. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991;13:372–374.

    Article  PubMed  CAS  Google Scholar 

  27. Marinos G. TNF receptors in patients with chronic hepatitis B viral infection. Gastroenterology. 1995;108:1453–1463.

    Article  PubMed  CAS  Google Scholar 

  28. Weiler-Normann C, Schramm C. Drug induced liver injury and its relationship to autoimmune hepatitis. J Hepatol. 2011;55:747–749.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francisco Colina.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Colina, F., Molero, A., Casís, B. et al. Infliximab-Related Hepatitis: A Case Study and Literature Review. Dig Dis Sci 58, 3362–3367 (2013). https://doi.org/10.1007/s10620-013-2698-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-013-2698-6

Keywords

Navigation